Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Waldschmidt

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993
Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytesZ Fabry, M Sandor, T F Gajewski, et al.
Genetics and Molecular Biology|June 4, 2011
Variation and genetic structure of Melipona quadrifasciata Lepeletier (Hymenoptera, Apidae) populations based on ISSR patternMarcília A Nascimento, Henrique Batalha-Filho, Ana M Waldschmidt, et al.
Investigative Radiology|July 17, 2025
Whole-body Dual-source Photon-counting CT in Multiple Myeloma-The Value of Virtual Monoenergetic Imaging for Lesion Vitality AssessmentAnke Heidemeier, Henner Huflage, Leo Rasche, et al.
Therapeutic Advances in Hematology|March 5, 2026
Real-world efficacy and tolerability of ixazomib-based combination therapies in advanced multiple myeloma and other plasma cell neoplasmsXiang Zhou, Julia Mersi, Christine Riedhammer, et al.
Frontiers in Oncology|September 6, 2021
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma PatientsVeronika Riebl, Sandra Maria Dold, Dagmar Wider, et al.
Journal of Cancer Research and Clinical Oncology|November 21, 2019
Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparibJulia Eismann, Yujing J Heng, Johannes M Waldschmidt, et al.
British Journal of Haematology|July 4, 2017
CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myelomaJohannes M Waldschmidt, Anna Simon, Dagmar Wider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivoG Hartmann, R D Weeratna, Z K Ballas, et al.
Journal of Cancer Research and Clinical Oncology|January 24, 2022
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myelomaJohannes M Waldschmidt, Stefan J Fruttiger, Dagmar Wider, et al.
Blood Advances|January 29, 2026
Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple MyelomaJulia Mersi, Lara Burow, Xiang Zhou, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993
Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytesZ Fabry, M Sandor, T F Gajewski, et al.
Genetics and Molecular Biology|June 4, 2011
Variation and genetic structure of Melipona quadrifasciata Lepeletier (Hymenoptera, Apidae) populations based on ISSR patternMarcília A Nascimento, Henrique Batalha-Filho, Ana M Waldschmidt, et al.
Investigative Radiology|July 17, 2025
Whole-body Dual-source Photon-counting CT in Multiple Myeloma-The Value of Virtual Monoenergetic Imaging for Lesion Vitality AssessmentAnke Heidemeier, Henner Huflage, Leo Rasche, et al.
Therapeutic Advances in Hematology|March 5, 2026
Real-world efficacy and tolerability of ixazomib-based combination therapies in advanced multiple myeloma and other plasma cell neoplasmsXiang Zhou, Julia Mersi, Christine Riedhammer, et al.
Frontiers in Oncology|September 6, 2021
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma PatientsVeronika Riebl, Sandra Maria Dold, Dagmar Wider, et al.
Journal of Cancer Research and Clinical Oncology|November 21, 2019
Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparibJulia Eismann, Yujing J Heng, Johannes M Waldschmidt, et al.
British Journal of Haematology|July 4, 2017
CXCL12 and CXCR7 are relevant targets to reverse cell adhesion-mediated drug resistance in multiple myelomaJohannes M Waldschmidt, Anna Simon, Dagmar Wider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivoG Hartmann, R D Weeratna, Z K Ballas, et al.
Journal of Cancer Research and Clinical Oncology|January 24, 2022
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myelomaJohannes M Waldschmidt, Stefan J Fruttiger, Dagmar Wider, et al.
Blood Advances|January 29, 2026
Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple MyelomaJulia Mersi, Lara Burow, Xiang Zhou, et al.
Pageof 7